Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment

INTRODUCTION: Diabetes mellitus is a progressive disease with cardiovascular complications. We evaluated the impact of a glucagon like peptide-1 (GLP-1) receptor agonist and sodium glucose cotransporter 2 (SGLT-2) inhibitors dapagliflozin and empagliflozin on renal and cardiac function in type 2 dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiramatsu, Takeyuki, Ito, Hiroki, Okumura, Shota, Asano, Yuko, Iguchi, Daiki, Furuta, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919219/
https://www.ncbi.nlm.nih.gov/pubmed/33371732
http://dx.doi.org/10.1177/1479164120971220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919219/
https://www.ncbi.nlm.nih.gov/pubmed/33371732
http://dx.doi.org/10.1177/1479164120971220

Ejemplares similares